These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16849655)

  • 1. Laws promote pediatric drug development.
    Kuehn BM
    JAMA; 2006 Jul; 296(3):271. PubMed ID: 16849655
    [No Abstract]   [Full Text] [Related]  

  • 2. Europe consults on more accurate prescribing for children.
    Rogers A
    Lancet; 2002 Mar; 359(9309):862. PubMed ID: 11897300
    [No Abstract]   [Full Text] [Related]  

  • 3. Problems of drug testing in children in the United States.
    Yaffe SJ
    Pediatr Pharmacol (New York); 1983; 3(3-4):339-48. PubMed ID: 11659147
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric drug administration. A primer on pediatric pharmacological considerations.
    Collopy KT; Friese G
    EMS Mag; 2010 Jun; 39(6):52-7. PubMed ID: 20593705
    [No Abstract]   [Full Text] [Related]  

  • 5. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation programs for pediatric drug research--do children really benefit?
    Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
    Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.
    Pediatrics; 1969 Mar; 43(3):463-5. PubMed ID: 5818481
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric Drug Formulations - Unintended Consequences of Legislation.
    Probst LA; Welch TR
    N Engl J Med; 2017 Feb; 376(8):795-796. PubMed ID: 28225679
    [No Abstract]   [Full Text] [Related]  

  • 9. The Therapeutic Orphan--30 Years Later. Proceedings of a joint conference of the Pediatric Pharmacology Research Unit Network, the European Society of Developmental Pharmacology, and the National Institute of Child Health and Human Development. Washington DC, USA, May 2, 1997.
    Pediatrics; 1999 Sep; 104(3 Pt 2):581-645. PubMed ID: 10532863
    [No Abstract]   [Full Text] [Related]  

  • 10. Is pediatric labeling really necessary?
    Christensen ML; Helms RA; Chesney RW
    Pediatrics; 1999 Sep; 104(3 Pt 2):593-7. PubMed ID: 10469796
    [No Abstract]   [Full Text] [Related]  

  • 11. [Importance of drug dosage in pediatric therapy].
    Brazier JL; Renaud H; Belkahia C
    Tunis Med; 1981; 59(4):257-64. PubMed ID: 7303165
    [No Abstract]   [Full Text] [Related]  

  • 12. JCAHO's compliance expectations for standardized concentrations. Rule of Six in pediatrics does not meet requirements.
    Jt Comm Perspect; 2004 May; 24(5):11. PubMed ID: 15224665
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy in pediatrics].
    Danin JP
    Rev Infirm; 1980 Jan; 30(1):44-53. PubMed ID: 6899353
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in pediatric pharmacology, therapeutics, and toxicology.
    Paul IM
    Adv Pediatr; 2010; 57(1):163-83. PubMed ID: 21056738
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological research in pediatrics: From neonates to adolescents.
    Rakhmanina NY; van den Anker JN
    Adv Drug Deliv Rev; 2006 Apr; 58(1):4-14. PubMed ID: 16533543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comments on drugs for pediatric use, in essentials for clinical use of drugs (the volume of chemical drugs and bioproducts, 2010 edition)].
    Jin YJ; Zhang YM
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):710-1. PubMed ID: 23158825
    [No Abstract]   [Full Text] [Related]  

  • 17. Pediatric critical care pharmacodynamics.
    Dionne R; McManus C
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):367-75. PubMed ID: 8398042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug development for children: how is pharma tackling an unmet need?
    Hawcutt DB; Smyth RL
    IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving pediatric dosing through pediatric initiatives: what we have learned.
    Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
    Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug dosage and contra-indications in neonate, infant and child (author's transl)].
    Pellegrin P; Lesne M
    J Pharm Belg; 1980; 35(4):289-300. PubMed ID: 7441479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.